IBS - Irritable Bowel Syndrome Clinical Trial
Official title:
The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
This clinical study aims to evaluate the use of i3.1 probiotic in participants who meet the Institute of Medicine (Canadian Consensus Criteria) case definition for ME/CFS and who may or may not be diagnosed with irritable bowel syndrome (IBS). The main questions it aims to answer are: - how effective is the usage of the i3.1 probiotic to reduce gastrointestinal (GI) inflammation and normalize the GI and systemic/brain interface? - how well is it working on IBS severity? The study sample is 100 male and female participants aged 45 to 70 years with ME/CFS (per the Canadian Consensus Criteria); one-half of the participants will have co-morbid IBS (per Rome IV criteria). Participants will receive an i3.1 or a placebo and be assessed at baseline, at eight weeks, and at 12 weeks (four weeks post-treatment completion).
This single-site comparison study will be performed on 100 participants, 45 to 70 years of age, who meet the Institute of Medicine (Canadian Consensus Criteria) case definition for ME/CFS and who may or may not be diagnosed with the irritable bowel syndrome (IBS), according to the Rome IV criteria. In this study, we will evaluate using the i3.1 probiotic compared to placebo. This is a randomized, placebo-controlled trial with four study arms that will include 25 participants per arm: Individuals with ME/CFS with and without IBS, who will take either the active medication i3.1 or placebo. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05118243 -
Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance
|
N/A | |
| Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05178017 -
Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)
|
N/A | |
| Completed |
NCT05197413 -
Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms
|
N/A | |
| Completed |
NCT04905524 -
Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)
|
N/A | |
| Recruiting |
NCT06297785 -
Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)
|
N/A | |
| Recruiting |
NCT05874830 -
The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome
|
N/A | |
| Active, not recruiting |
NCT04723056 -
Zemedy Application for Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT05565612 -
Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome
|
N/A | |
| Recruiting |
NCT03131414 -
The IMAGINE-SPOR CIHR Chronic Disease Network
|
||
| Completed |
NCT03333291 -
Fecal Transplantation in Patients With IBS
|
N/A | |
| Completed |
NCT03449628 -
L. Casei DG® in Patients With Irritable Bowel Syndrome.
|
N/A | |
| Recruiting |
NCT06215222 -
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
|
||
| Completed |
NCT05016596 -
Postprandial Lipids in IBS and Nutritional Treatment
|
N/A | |
| Recruiting |
NCT04760353 -
The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT06426745 -
Split-dose Versus Single-dose Bowel Preparation for Colonoscopy
|
N/A | |
| Recruiting |
NCT04217733 -
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
|
Phase 3 | |
| Completed |
NCT03178877 -
The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors
|
N/A | |
| Recruiting |
NCT05990764 -
Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
|
N/A | |
| Completed |
NCT03948854 -
Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients
|
N/A |